These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18570611)

  • 41. Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
    Parenti D; Murray CW
    Arthritis Rheum; 2001 Jun; 44(6):1470-1; author reply 1473-6. PubMed ID: 11407711
    [No Abstract]   [Full Text] [Related]  

  • 42. Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans.
    Pagnano M; Westrich G
    Osteoarthritis Cartilage; 2005 Sep; 13(9):751-61. PubMed ID: 15967686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraarticular Hyaluronic Acid Preparations for Knee Osteoarthritis: Are Some Better Than Others?
    Webner D; Huang Y; Hummer CD
    Cartilage; 2021 Dec; 13(1_suppl):1619S-1636S. PubMed ID: 34044600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.
    Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R
    J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis.
    Rutjes AW; Jüni P; da Costa BR; Trelle S; Nüesch E; Reichenbach S
    Ann Intern Med; 2012 Aug; 157(3):180-91. PubMed ID: 22868835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyaluronic acid injections relieve knee pain.
    Modawal A; Ferrer M; Choi HK; Castle JA
    J Fam Pract; 2005 Sep; 54(9):758-67. PubMed ID: 16144589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee.
    Hammesfahr JF; Knopf AB; Stitik T
    Am J Orthop (Belle Mead NJ); 2003 Jun; 32(6):277-83. PubMed ID: 12834190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
    Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
    Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
    Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
    Osteoarthritis Cartilage; 2005 Feb; 13(2):104-10. PubMed ID: 15694571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study.
    Kearey P; Popple AE; Warren J; Davis T; Bellamy N;
    Curr Med Res Opin; 2017 Mar; 33(3):409-419. PubMed ID: 27848271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
    Conrozier T; Vignon E
    Clin Exp Rheumatol; 2005; 23(5):711-6. PubMed ID: 16173254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudoseptic reactions to Hylan viscosupplementation: diagnosis and treatment.
    Magilavy DB; McPherson JM; Polisson R
    Clin Orthop Relat Res; 2004 Dec; (429):349-50; author reply 350-1. PubMed ID: 15577509
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
    Zietz PM; Selesnick H
    Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse reaction to Hylan GF-20.
    Allen E; Krohn K
    J Rheumatol; 2000 Jun; 27(6):1572. PubMed ID: 10852302
    [No Abstract]   [Full Text] [Related]  

  • 56. Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada.
    Petrella RJ; Wakeford C
    Drug Des Devel Ther; 2015; 9():5633-40. PubMed ID: 26508838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
    Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
    Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-articular injections of hyaluronic acid (viscosupplementation) in the haemophilic knee.
    Rodriguez-Merchan EC
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):580-3. PubMed ID: 22885769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee.
    Zardawi IM
    J Bone Joint Surg Am; 2003 Dec; 85(12):2484; author reply 2484-5. PubMed ID: 14668528
    [No Abstract]   [Full Text] [Related]  

  • 60. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H; Burkhardt D; Sambrook P; March L
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.